Market Place
Sourcing Support
Avit`s Generics Sitagliptin Receives Approval in US
02 Jun 2025 //
FDA
Dr Reddy`s Generics Sitagliptin Receives Approval in US
30 May 2025 //
FDA
MSN`s Generics Sacubitril Receives Tentative Approval in US
29 May 2025 //
FDA
Boehringer `s Biologics Spevigo Receives Suppl Approval in US
28 May 2025 //
FDA
BMS`s Biologics Opdivo Qvantig Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Yervoy Receives Suppl Approval in US
23 May 2025 //
FDA
Eli Lilly`s Biologics Ebglyss Receives Suppl Approval in US
22 May 2025 //
FDA
Celltrion`s Biologics Herzuma Receives Suppl Approval in US
22 May 2025 //
FDA
Merck`s Biologics Keytruda Receives Suppl Approval in US
22 May 2025 //
FDA
GSK`s Biologics Nucala Receives Suppl Approval in US
22 May 2025 //
FDA
Samsung Bioepis`s Biologics Hadlima Receives Suppl Approval in US
21 May 2025 //
FDA
Mankind Pharma`s Generics Proparacaine Receives Approval in US
21 May 2025 //
FDA
Genentech`s Biologics Susvimo Receives Suppl Approval in US
21 May 2025 //
FDA
Handa Pharma`s Generics Varenicline Receives Approval in US
21 May 2025 //
FDA
Boehringer`s Biologics Cyltezo Receives Suppl Approval in US
20 May 2025 //
FDA
Amgen`s Biologics Amjevita Receives Suppl Approval in US
20 May 2025 //
FDA
Sandoz`s Generics Sugammadex Receives Tentative Approval in US
20 May 2025 //
FDA
Galenicum`s Generics Diazepam Receives Approval in US
19 May 2025 //
FDA
Qilu Pharma`s Generics Olanzapine Receives Approval in US
16 May 2025 //
FDA
Incyte`s Biologics Zynyz Receives Suppl Approval in US
15 May 2025 //
FDA
Genentech`s Biologics Piasky Receives Suppl Approval in US
14 May 2025 //
FDA
Ascent`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Biocon`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Sunshine`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Macleod`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Alembic`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
InvaGen`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Dr Reddy`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
AbbVie`s Biologics Skyrizi Receives Suppl Approval in US
07 May 2025 //
FDA
Chemi SpA`s Generics Glatiramer Receives Approval in US
07 May 2025 //
FDA
Lupin`s Generics Raltegravir Receives Approval in US
07 May 2025 //
FDA
BMS`s Augtyro Receives Approval in Canada
07 May 2025 //
HEALTH CANADA
Sanofi-Aventis`s Tzield Receives Approval in Canada
05 May 2025 //
HEALTH CANADA
Apotex`s Generics Ticagrelor Receives Approval in US
01 May 2025 //
FDA
Apotex`s Generics Ticagrelor Receives Tentative Approval in US
01 May 2025 //
FDA
Sterinova`s Generics Midazolam NaCl Receives Approval in US
01 May 2025 //
FDA
Aspiro`s Generics Zinc Sulfate Receives Approval in US
01 May 2025 //
FDA
Graviti Pharma`s Generics Tamsulosin HCl Receives Approval in US
01 May 2025 //
FDA
BeiGene`s Biologics Tevimbra Receives Suppl Approval in US
01 May 2025 //
FDA
Janssen`s Biologic NIpocalimab Receives Approval in US
29 Apr 2025 //
FDA
Kashiv Bio`s Biologic Releuko Receives Approval in US
29 Apr 2025 //
FDA
Amgen`s Biologic Blincyto Receives Approval in US
29 Apr 2025 //
FDA
Celltrion`s Biologic Steqeyma Receives Suppl Approval in US
28 Apr 2025 //
FDA
Ipsen Biopharma`s Iqirvo Receives Approval in Canada
25 Apr 2025 //
HEALTH CANADA
Akeso`s Biologic Penpulimab Receives Suppl Approval in US
23 Apr 2025 //
FDA
Kashiv Bio`s Biologic FYLNETRA Receives Suppl Approval in US
23 Apr 2025 //
FDA
BeiGene`s Biologic Tevimbra Receives Suppl Approval in US
22 Apr 2025 //
FDA
Amgen`s Biologic Bkemv Receives Suppl Approval in US
18 Apr 2025 //
FDA
Janseen`s Biologic Simponi Aria Receives Suppl Approval in US
18 Apr 2025 //
FDA
Centocor`s Biologic Simponi Receives Suppl Approval in US
18 Apr 2025 //
FDA
Aurobindo`s Generics Esomeprazole Receives Approval in US
15 Apr 2025 //
FDA
Fresenius Kabi`s Biologic Otulfi Receives Suppl Approval in US
14 Apr 2025 //
FDA
Micro Labs`s Generics Latanoprost Receives Approval in US
14 Apr 2025 //
FDA
Amicus Therapeutics`s Pombiliti Receives Approval in Canada
14 Apr 2025 //
HEALTH CANADA
BMS`s Biologic Opdivo Receives Suppl Approval in US
11 Apr 2025 //
FDA
BMS`s Biologic Yervoy Receives Suppl Approval in US
11 Apr 2025 //
FDA
Argenx`s Biologic Vyvgart Hytrulo Receives Suppl Approval in US
10 Apr 2025 //
FDA
Eli Lilly`s Biologic Cyramza Receives Suppl Approval in US
07 Apr 2025 //
FDA
Dermavant Sciences`s Nduvra Receives Approval in Canada
04 Apr 2025 //
HEALTH CANADA
